Literature DB >> 33919517

The Role of Macrophages in Cancer Development and Therapy.

Ewa Cendrowicz1, Zuzanna Sas2, Edwin Bremer1, Tomasz P Rygiel2.   

Abstract

Macrophages are critical mediators of tissue homeostasis and influence various aspects of immunity. Tumor-associated macrophages are one of the main cellular components of the tumor microenvironment. Depending on their activation status, macrophages can exert a dual influence on tumorigenesis by either antagonizing the cytotoxic activity of immune cells or, less frequently, by enhancing antitumor responses. In most situations, TAMs suppress T cell recruitment and function or regulate other aspects of tumor immunity. The importance of TAMs targeting in cancer therapy is derived from the strong association between the high infiltration of TAMs in the tumor tissue with poor patient prognosis. Several macrophage-targeting approaches in anticancer therapy are developed, including TAM depletion, inhibition of new TAM differentiation, or re-education of TAM activation for cancer cell phagocytosis. In this review, we will describe the role of TAMs in tumor development, including such aspects as protumorigenic inflammation, immune suppression, neoangiogenesis, and enhancement of tissue invasion and distant metastasis. Furthermore, we will discuss therapeutic approaches that aim to deplete TAMs or, on the contrary, re-educate TAMs for cancer cell phagocytosis and antitumor immunity.

Entities:  

Keywords:  immune suppression; immunotherapy; macrophage; tumor; tumor microenvironment; tumor-associated macrophages

Year:  2021        PMID: 33919517     DOI: 10.3390/cancers13081946

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  25 in total

Review 1.  The pleiotropic mode and molecular mechanism of macrophages in promoting tumor progression and metastasis.

Authors:  Xingxing Zhang; Wenxiu Bai; Lisha Hu; Hualan Ha; Yuelin Du; Wei Xiong; Hongbo Wang; Panfeng Shang
Journal:  Clin Transl Oncol       Date:  2022-09-07       Impact factor: 3.340

2.  Iron Oxide Nanoparticles for Visualization of Prostate Cancer in MRI.

Authors:  Avan Kader; Jan O Kaufmann; Dilyana B Mangarova; Jana Moeckel; Julia Brangsch; Lisa C Adams; Jing Zhao; Carolin Reimann; Jessica Saatz; Heike Traub; Rebecca Buchholz; Uwe Karst; Bernd Hamm; Marcus R Makowski
Journal:  Cancers (Basel)       Date:  2022-06-13       Impact factor: 6.575

Review 3.  Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy.

Authors:  Jianying Li; Chelsea Bolyard; Gang Xin; Zihai Li
Journal:  Front Cell Dev Biol       Date:  2021-12-20

Review 4.  The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.

Authors:  Kuba Retecki; Milena Seweryn; Agnieszka Graczyk-Jarzynka; Malgorzata Bajor
Journal:  Cancers (Basel)       Date:  2021-11-29       Impact factor: 6.639

Review 5.  Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End.

Authors:  Angeliki Datsi; Rüdiger V Sorg
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

6.  FUCA2 Is a Prognostic Biomarker and Correlated With an Immunosuppressive Microenvironment in Pan-Cancer.

Authors:  Anyuan Zhong; Ting Chen; Yufei Xing; Xue Pan; Minhua Shi
Journal:  Front Immunol       Date:  2021-10-20       Impact factor: 7.561

7.  Cancer and Autoimmune Diseases: A Tale of Two Immunological Opposites?

Authors:  Zeev Elkoshi
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

Review 8.  Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.

Authors:  Giasemi C Eptaminitaki; Nora Wolff; Dimitris Stellas; Konstantinos Sifakis; Stavroula Baritaki
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

Review 9.  Metabolic Hormones Modulate Macrophage Inflammatory Responses.

Authors:  Matthew J Batty; Gwladys Chabrier; Alanah Sheridan; Matthew C Gage
Journal:  Cancers (Basel)       Date:  2021-09-17       Impact factor: 6.639

Review 10.  Circadian and Immunity Cycle Talk in Cancer Destination: From Biological Aspects to In Silico Analysis.

Authors:  Mina Mirian; Amirali Hariri; Mahtasadat Yadollahi; Mohammad Kohandel
Journal:  Cancers (Basel)       Date:  2022-03-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.